Article Information
History
- May 14, 2020.
Article Versions
- Version 1 (March 30, 2020 - 08:47).
- You are currently viewing Version 2 of this article (May 14, 2020 - 15:15).
- Version 3 (May 19, 2020 - 14:57).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Daniel Roelfs, MSc1,*,
- Dag Alnæs, PhD1,
- Oleksandr Frei, PhD1,
- Dennis van der Meer, PhD1,2,
- Olav B. Smeland, PhD1,
- Ole A. Andreassen, PhD1,
- Lars T. Westlye, PhD1,3 and
- Tobias Kaufmann, PhD1,*
- 1NORMENT, KG Jebsen Centre for Neurodevelopmental Disorders, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 2School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
- 3Department of Psychology, University of Oslo, Oslo, Norway
- ↵*Correspondence: Daniel Roelfs & Tobias Kaufmann, Ph.D. Email: daniel.roelfs{at}medisin.uio.no, tobias.kaufmann{at}medisin.uio.no, Postal address: OUS, PO Box 4956 Nydalen, 0424 Oslo, Norway, Telephone: +47 23 02 73 50, Fax: +47 23 02 73 33
Posted May 14, 2020.
